{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:34:21Z","timestamp":1793475261645,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008644","name":"Japan Diabetes Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008644","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00592-018-1244-6","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T04:50:30Z","timestamp":1540270230000},"page":"309-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-041X","authenticated-orcid":false,"given":"Mitsuyoshi","family":"Takahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Katakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Shiraiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushige","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Ayame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Tomonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taka-aki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"issue":"Suppl 2","key":"1244_CR1","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/S0168-8227(00)00183-2","volume":"50","author":"KM Narayan","year":"2000","unstructured":"Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F (2000) Diabetes\u2013a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 50(Suppl 2):S77\u2013S84","journal-title":"Diabetes Res Clin Pract"},{"key":"1244_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","volume":"276","author":"MC Weinstein","year":"1996","unstructured":"Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB (1996) Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276:1253\u20131258","journal-title":"JAMA"},{"key":"1244_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/hec.901","volume":"13","author":"G Richardson","year":"2004","unstructured":"Richardson G, Manca A (2004) Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ 13:1203\u20131210","journal-title":"Health Econ"},{"key":"1244_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R (1996) EuroQol: the current state of play. Health Policy 37:53\u201372","journal-title":"Health Policy"},{"key":"1244_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/027298902400448902","volume":"22","author":"P Clarke","year":"2002","unstructured":"Clarke P, Gray A, Holman R (2002) Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 22:340\u2013349","journal-title":"Med Decis Making"},{"key":"1244_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hec.910","volume":"14","author":"A Bagust","year":"2005","unstructured":"Bagust A, Beale S (2005) Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ 14:217\u2013230","journal-title":"Health Econ"},{"key":"1244_CR7","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.2337\/dc11-2478","volume":"35","author":"P Zhang","year":"2012","unstructured":"Zhang P, Brown MB, Bilik D, Ackermann RT, Li R, Herman WH (2012) Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 35:2250\u20132256","journal-title":"Diabetes Care"},{"key":"1244_CR8","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.3390\/ijerph110504939","volume":"11","author":"AA Kiadaliri","year":"2014","unstructured":"Kiadaliri AA, Gerdtham UG, Eliasson B, Gudbjornsdottir S, Svensson AM, Carlsson KS (2014) Health utilities of type 2 diabetes-related complications: a cross-sectional study in Sweden. Int J Environ Res Public Health 11:4939\u20134952","journal-title":"Int J Environ Res Public Health"},{"key":"1244_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1177\/0272989X16658660","volume":"36","author":"T Peasgood","year":"2016","unstructured":"Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H, Kruger J (2016) The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with type I diabetes. Med Decis Making 36:1020\u20131033","journal-title":"Med Decis Making"},{"key":"1244_CR10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553\u20131579","journal-title":"Diabetes Care"},{"key":"1244_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.bdj.2014.907","volume":"217","author":"L Casanova","year":"2014","unstructured":"Casanova L, Hughes FJ, Preshaw PM (2014) Diabetes and periodontal disease: a two-way relationship. Br Dent J 217:433\u2013437","journal-title":"Br Dent J"},{"key":"1244_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/hec.1006","volume":"14","author":"S Petrou","year":"2005","unstructured":"Petrou S, Hockley C (2005) An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Econ 14:1169\u20131189","journal-title":"Health Econ"},{"key":"1244_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1524-4733.2006.00108.x","volume":"9","author":"M Bharmal","year":"2006","unstructured":"Bharmal M, Thomas J (2006) Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9:262\u2013271","journal-title":"Value Health"},{"key":"1244_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/hec.866","volume":"13","author":"J Brazier","year":"2004","unstructured":"Brazier J, Roberts J, Tsuchiya A, Busschbach J (2004) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13:873\u2013884","journal-title":"Health Econ"},{"key":"1244_CR15","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727\u20131736","journal-title":"Qual Life Res"},{"key":"1244_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1477-7525-12-74","volume":"12","author":"CB Agborsangaya","year":"2014","unstructured":"Agborsangaya CB, Lahtinen M, Cooke T, Johnson JA (2014) Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population. Health Qual Life Outcomes 12:74","journal-title":"Health Qual Life Outcomes"},{"key":"1244_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vhri.2015.11.003","volume":"9","author":"P Wang","year":"2016","unstructured":"Wang P, Luo N, Tai ES, Thumboo J (2016) The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value Health Reg Issues 9:57\u201362","journal-title":"Value Health Reg Issues"},{"key":"1244_CR18","first-page":"47","volume":"64","author":"S Ikeda","year":"2015","unstructured":"Ikeda S, Shiroiwa T, Igarashi A et al (2015) Developing a Japanese version of the EQ-5D-5L value set. J Natl Inst Public Health 64:47\u201355","journal-title":"J Natl Inst Public Health"},{"key":"1244_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13340-018-0356-0","volume":"9","author":"M Haneda","year":"2018","unstructured":"Haneda M, Noda M, Origasa H et al (2018) Japanese clinical practice guideline for diabetes 2016. Diabetol Int 9:1\u201345","journal-title":"Diabetol Int"},{"key":"1244_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1524-4733.2010.00695.x","volume":"13","author":"EM Pullenayegum","year":"2010","unstructured":"Pullenayegum EM, Tarride JE, Xie F, Goeree R, Gerstein HC, O\u2019Reilly D (2010) Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health 13:487\u2013494","journal-title":"Value Health"},{"key":"1244_CR21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jval.2017.05.018","volume":"20","author":"M Laxy","year":"2017","unstructured":"Laxy M, Wilson ECF, Boothby CE, Griffin SJ (2017) Incremental costs and cost effectiveness of intensive treatment in individuals with type 2 diabetes detected by screening in the ADDITION-UK trial: an update with empirical trial-based cost data. Value Health 20:1288\u20131298","journal-title":"Value Health"},{"key":"1244_CR22","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589","journal-title":"N Engl J Med"},{"key":"1244_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/jamainternmed.2014.2894","volume":"174","author":"S Vijan","year":"2014","unstructured":"Vijan S, Sussman JB, Yudkin JS, Hayward RA (2014) Effect of patients\u2019 risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med 174:1227\u20131234","journal-title":"JAMA Intern Med"},{"key":"1244_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405\u2013412","journal-title":"BMJ"},{"key":"1244_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/jdi.12778","volume":"9","author":"Y Ikeda","year":"2018","unstructured":"Ikeda Y, Kubo T, Oda E, Abe M, Tokita S (2018) Incidence rate and patient characteristics of severe hypoglycemia in treated type 2 diabetes mellitus patients in Japan: retrospective diagnosis procedure combination database analysis. J Diabetes Investig 9:925\u2013936","journal-title":"J Diabetes Investig"},{"key":"1244_CR26","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1111\/j.1464-5491.2012.03689.x","volume":"29","author":"YT Shim","year":"2012","unstructured":"Shim YT, Lee J, Toh MP, Tang WE, Ko Y (2012) Health-related quality of life and glycaemic control in patients with Type 2 diabetes mellitus in Singapore. Diabet Med 29:e241\u2013e248","journal-title":"Diabet Med"},{"key":"1244_CR27","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1185\/030079906X115757","volume":"22","author":"CJ Currie","year":"2006","unstructured":"Currie CJ, Morgan CL, Poole CD, Sharplin P, Lammert M, McEwan P (2006) Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin 22:1523\u20131534","journal-title":"Curr Med Res Opin"},{"key":"1244_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2012.01.026","volume":"222","author":"JH Southerland","year":"2012","unstructured":"Southerland JH, Moss K, Taylor GW et al (2012) Periodontitis and diabetes associations with measures of atherosclerosis and CHD. Atherosclerosis 222:196\u2013201","journal-title":"Atherosclerosis"},{"key":"1244_CR29","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1001\/archinte.161.16.1989","volume":"161","author":"P Bytzer","year":"2001","unstructured":"Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M (2001) Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 161:1989\u20131996","journal-title":"Arch Intern Med"},{"key":"1244_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.7326\/0003-4819-92-2-318","volume":"92","author":"C Frimodt-Moller","year":"1980","unstructured":"Frimodt-Moller C (1980) Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med 92:318\u2013321","journal-title":"Ann Intern Med"},{"key":"1244_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2337\/diaclin.33.1.40","volume":"33","author":"M Duff","year":"2015","unstructured":"Duff M, Demidova O, Blackburn S, Shubrook J (2015) Cutaneous manifestations of diabetes mellitus. Clin Diabetes 33:40\u201348","journal-title":"Clin Diabetes"},{"key":"1244_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1056\/NEJM198107233050403","volume":"305","author":"AL Rosenbloom","year":"1981","unstructured":"Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M (1981) Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N Engl J Med 305:191\u2013194","journal-title":"N Engl J Med"},{"key":"1244_CR33","doi-asserted-by":"publisher","first-page":"a2718","DOI":"10.1136\/bmj.a2718","volume":"337","author":"SP Cohen","year":"2008","unstructured":"Cohen SP, Argoff CE, Carragee EJ (2008) Management of low back pain. BMJ 337:a2718","journal-title":"BMJ"},{"key":"1244_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.joca.2009.08.010","volume":"18","author":"M Blagojevic","year":"2010","unstructured":"Blagojevic M, Jinks C, Jeffery A, Jordan KP (2010) Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthr Cartil 18:24\u201333","journal-title":"Osteoarthr Cartil"},{"key":"1244_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jdiacomp.2015.11.016","volume":"30","author":"JP Bae","year":"2016","unstructured":"Bae JP, Lage MJ, Mo D, Nelson DR, Hoogwerf BJ (2016) Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009 to 2011. J Diabetes Complicat 30:212\u2013220","journal-title":"J Diabetes Complicat"},{"key":"1244_CR36","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.2337\/dc08-0662","volume":"31","author":"J Cederholm","year":"2008","unstructured":"Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjornsdottir S (2008) Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 31:2038\u20132043","journal-title":"Diabetes Care"},{"key":"1244_CR37","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2105\/AJPH.2016.303299","volume":"106","author":"AM Goman","year":"2016","unstructured":"Goman AM, Lin FR (2016) Prevalence of hearing loss by severity in the United States. Am J Public Health 106:1820\u20131822","journal-title":"Am J Public Health"},{"key":"1244_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-149-1-200807010-00231","volume":"149","author":"KE Bainbridge","year":"2008","unstructured":"Bainbridge KE, Hoffman HJ, Cowie CC (2008) Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med 149:1\u201310","journal-title":"Ann Intern Med"},{"key":"1244_CR39","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.2337\/dc10-2161","volume":"34","author":"KE Bainbridge","year":"2011","unstructured":"Bainbridge KE, Hoffman HJ, Cowie CC (2011) Risk factors for hearing impairment among U.S. adults with diabetes: National Health and Nutrition Examination Survey 1999\u20132004. Diabetes Care 34:1540\u20131545","journal-title":"Diabetes Care"},{"key":"1244_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ahj.2005.04.007","volume":"151","author":"PJ Bradshaw","year":"2006","unstructured":"Bradshaw PJ, Jamrozik KD, Gilfillan IS, Thompson PL (2006) Asymptomatic long-term survivors of coronary artery bypass surgery enjoy a quality of life equal to the general population. Am Heart J 151:537\u2013544","journal-title":"Am Heart J"},{"key":"1244_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2867","author":"K Pickwell","year":"2017","unstructured":"Pickwell K, Siersma V, Kars M et al (2017) Minor amputation does not negatively affect health-related quality of life as compared with conservative treatment in patients with a diabetic foot ulcer: an observational study. Diabetes Metab Res Rev. \n                    https:\/\/doi.org\/10.1002\/dmrr.2867","journal-title":"Diabetes Metab Res Rev"},{"key":"1244_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8727(00)00133-1","volume":"14","author":"G Ragnarson Tennvall","year":"2000","unstructured":"Ragnarson Tennvall G, Apelqvist J (2000) Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complicat 14:235\u2013241","journal-title":"J Diabetes Complicat"},{"key":"1244_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","volume":"26","author":"RB Rutherford","year":"1997","unstructured":"Rutherford RB, Baker JD, Ernst C et al (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26:517\u2013538","journal-title":"J Vasc Surg"},{"key":"1244_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/pubmed\/fdi025","volume":"27","author":"H Jia","year":"2005","unstructured":"Jia H, Lubetkin EI (2005) The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf) 27:156\u2013164","journal-title":"J Public Health (Oxf)"},{"key":"1244_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12955-017-0773-y","volume":"15","author":"R Busutil","year":"2017","unstructured":"Busutil R, Espallardo O, Torres A, Martinez-Galdeano L, Zozaya N, Hidalgo-Vega A (2017) The impact of obesity on health-related quality of life in Spain. Health Qual Life Outcomes 15:197","journal-title":"Health Qual Life Outcomes"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-018-1244-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-018-1244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-018-1244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T09:57:10Z","timestamp":1571824630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-018-1244-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1007\/s00592-018-1244-6","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]},"assertion":[{"value":"10 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"According to the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan, written informed consent from the participants was substituted for by their oral consent after notification of relevant information on the study and ensured opportunities for refusal, on the ground of the study\u2019s intervention- and invasiveness-free nature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}